NFE2L2 and non-small cell lung carcinoma: APOC1 mediated the conversion of M2 macrophages into M1 macrophages through the NRF2/HO-1 pathway, reducing the sensitivity of NSCLC for anti-PD-1 immunotherapy by promoting ferroptosis [38].